Come stop by to see CPP as we will be exhibiting at the AAP National Conference & Exhibition, alongside Nationwide Children’s Hospital (booth # 2217) in the exhibit hall during the conference!
Related Posts
Patient recall is an essential part of a practice workflow in healthcare settings. As practices fill schedules this summer scheduling…
The first of the year is usually when vaccine manufacturers increase their prices therefore, it is important that practices evaluate…
CPP members don’t forget that Friday, April,19th, is the last day to pre-book Fluzone®, High-Dose Fluzone and Flublok® vaccines for…
Measles is on the rise across the world and country. As flu, COVID and RSV continue to be a concern,…
Vaccine Updates – Pfizer Recently, Pfizer communicated some changes to their vaccine portfolio. The addition of Pfizer’s Penbraya™, a new pentavalent…
As the school year is coming to an end, summer is often a popular time for children and adolescents to…
One of the benefits of joining a vaccine buying group is the additional administrative support that can be invaluable for…
It’s time for your annual vaccine management check-up! This tool is designed to help you check up on the financial…
Vaccine uncertainty has led to more individuals questioning vaccines and delaying or refusing vaccines as the pandemic has increased uncertainty…
As winter storms sweep through different parts of the country, maintaining the integrity of vaccines becomes a critical concern for…
Dynavax is hosting a live webinar series on July 25th and 26th 2023 discussing hepatitis B vaccination in support of World Hepatitis Day, which is…
Protecting patients against vaccine-preventable diseases is a critical part of keeping patients healthy. Physician buying groups enable practices to optimize…
Great News! CPP has renewed our partnership with GoCheck Kids, a leading pediatric vision screening platform that aligns with the AAP recommendations…
Friday, March 31, 2023, is the last day to prebook Fluzone®, High-Dose Fluzone and Flublok® vaccines for the 2023-2024 flu…
RSV MONOCLONAL ANTIBODY (INFANTS) On August 3rd, the ACIP voted unanimously and recommended the use of Sanofi and AstraZeneca’s Beyfortus™,…